Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × toripalimab × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 12 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 5 Advanced Solid Tumor 5 Uterine Cervical Neoplasms 4 Recurrence 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Solid Tumor 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stage IB-IIIB NSCLC 1 Solid Tumor, Adult 1 Solid Cancer 1

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡